Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Right and Wrong Business Reactions to Irma, Plus Some International Moves on Global Warming
Right and Wrong Business Reactions to Irma, Plus Some International Moves on Global Warming
On this Market Foolery podcast, host Chris Hill, Motley Fool Pro and Options' Jeff Fischer, and Motley Fool Options and Pro Canada's Jim Gillies start with a quick delve into their expectations....
3 Dividend Stocks You'll Wish You'd Bought 10 Years From Now
3 Dividend Stocks You'll Wish You'd Bought 10 Years From Now
Buying solid dividend stocks and holding them over the long term is arguably the best way patient investors can predictably generate wealth over the long term. But the task of identifying the....
This Is Bad News for Third-Quarter Bank Earnings
This Is Bad News for Third-Quarter Bank Earnings
While most banks should turn in solid performances for the third quarter, there's reason to believe that revenue and profits will be weighed down by at least one ongoing trend. Over the past week,....
This Week in Solar
This Week in Solar
It was another wild week for the solar industry. There appears to be more growth than anticipated, next-generation products are starting to take off, and projects due two years from now are....
Should I Buy Travelers Stock Despite Hurricanes Harvey And Irma?
Should I Buy Travelers Stock Despite Hurricanes Harvey And Irma?
If history is our guide, then policy demand and premium pricing strength following Hurricanes Harvey and Irma could make it the perfect time to buy shares in property and casualty insurer....
How Long Will It Take Citigroup's Stock to Double?
How Long Will It Take Citigroup's Stock to Double?
The last decade has been tumultuous for Citigroup (NYSE: C), which nearly failed in the financial crisis and has been focused on turning things around ever sense. But if the bank continues on its....
How Much Will Higher Interest Rates Help Bank of America?
How Much Will Higher Interest Rates Help Bank of America?
With the Federal Reserve meeting next week to decide whether to raise interest rates, it's worth reviewing Bank of America's (NYSE: BAC) latest interest rate sensitivity analysis. The nation's....
Here's Why Higher Interest Rates Matter to JPMorgan Chase
Here's Why Higher Interest Rates Matter to JPMorgan Chase
Interest rates are one of the most important catalysts for bank stocks right now, with higher rates promising improved profitability throughout the industry. Given that the Federal Reserve will....
3 Stocks You Can Keep Forever
3 Stocks You Can Keep Forever
The first thing that I ask myself when looking for stocks that I could hold in my portfolio forever is "Will this business be around in 50 years?" For example, people will need safe places to....
Will the Federal Reserve Raise Interest Rates Next Week?
Will the Federal Reserve Raise Interest Rates Next Week?
One of the most important things that will happen in the market next week is the Federal Reserve's announcement about whether it will raise interest rates for the third time this year. But while....
7 Things Bank of America Wants You to Know
7 Things Bank of America Wants You to Know
Bank of America (NYSE: BAC) recently presented at the Barclays Global Financial Services Conference, and the general theme of the company's presentation was that Bank of America has come a long....
Evotec: Die nächste Kooperation
Evotec: Die nächste Kooperation
Die nächste Kooperation meldet heute der Wirkstoffhersteller Evotec. Zusammen mit MaRS Innovation wurde eine Kooperation mit der Bezeichnung „LAB150“ vereinbart. Gemeinsam will man in Toronto....
Investing in Venture Capital: A Step-by-Step Guide
Investing in Venture Capital: A Step-by-Step Guide
If you want to get in on the ground floor of some of the most exciting business ideas available, investing in venture capital can be your gateway to a whole new world of investment opportunities.....
3 PR Scandals Creating Intriguing Buying Opportunities
3 PR Scandals Creating Intriguing Buying Opportunities
If you're an investor, arguably the last thing you want or expect to see from any of the companies you own is a scandal or public relations nightmare. But let's face the facts: It happens from....
Here's Why Intercept Pharmaceuticals Is Tumbling Today
Here's Why Intercept Pharmaceuticals Is Tumbling Today
Shares of Intercept Pharmaceuticals (NASDAQ: ICPT), a commercial stage biotech focused on liver diseases, declined by 17% as of 10:30 a.m. EDT Tuesday. The fall is attributable to a letter that....
Wells Fargo's Growth Rate Is Slowing Down
Wells Fargo's Growth Rate Is Slowing Down
For investors in Wells Fargo (NYSE: WFC), one of the most important questions right now facing the bank is whether, in the wake of its fake-account scandal, it can continue producing the same type....
Bank of America Stock: How Many Years Will It Take to Double?
Bank of America Stock: How Many Years Will It Take to Double?
You never know what will happen to any company, but assuming that Bank of America (NYSE: BAC) continues on its current course, shares of the nation's second biggest bank are on track to double in....
2 Stocks to Buy With Dividends Yielding More Than 4% and 5%, Respectively
2 Stocks to Buy With Dividends Yielding More Than 4% and 5%, Respectively
Dividend stocks can be wonderful. Dividends can provide current income or, when reinvested, they can help power total capital appreciation. But you need to tread carefully once you get into....
How Long Will It Take JPMorgan Chase's Stock to Double?
How Long Will It Take JPMorgan Chase's Stock to Double?
There's nothing better in the world of investing than seeing a stock you buy creep into triple-digit return territory. Some stocks only take months to do so, while others take years, if not....
5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition
5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition
Gilead Sciences' (NASDAQ: GILD) executives answered several questions about its pending acquisition of Kite Pharma (NASDAQ: KITE) last week at the Citi biotech conference. However, that discussion....
My Credit Score Is 700. Now What?
My Credit Score Is 700. Now What?
A credit score of 700 is considered "good" by FICO, and although it's not in "very good" or "exceptional" territory, it should qualify you for the best terms on most loans. Here's how you can use....
These 3 Stocks Just Raised Their Dividends
These 3 Stocks Just Raised Their Dividends
Labor Day has come and gone, and with it a late August that was light on dividend raises. Now that we're in the new month, the pace of distribution hikes from the market's companies should pick up....
In Your 40s? You Might Want to Buy This Stock
In Your 40s? You Might Want to Buy This Stock
If you're a 40-year-old investor, you're probably not planning on retiring for another 20 years or more. While that may be bit of a downer for those looking forward to the freedom that retirement....
Why I Love Berkshire Hathaway
Why I Love Berkshire Hathaway
It's the investment vehicle of arguably the most legendary investor in the world, its portfolio never seems to stop growing, and its historical returns have been leagues better than many stock....
These Charts Explain Why Goldman Sachs' CEO Is Unnerved by the Markets Right Now
These Charts Explain Why Goldman Sachs' CEO Is Unnerved by the Markets Right Now
The chairman and CEO of Goldman Sachs (NYSE: GS), Lloyd Blankfein, added his voice to a chorus of high-profile financiers that have expressed concern about the current state of the markets."Things....